- Home
- BBAR vs IMCR Comparison
BBAR vs IMCR Comparison
Compare BBAR & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- IMCR
- Stock Information
- Founded
- BBAR 1886
- IMCR 2008
- Country
- BBAR Argentina
- IMCR United Kingdom
- Employees
- BBAR N/A
- IMCR N/A
- Industry
- BBAR Commercial Banks
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBAR Finance
- IMCR Health Care
- Exchange
- BBAR Nasdaq
- IMCR Nasdaq
- Market Cap
- BBAR 2.7B
- IMCR 1.7B
- IPO Year
- BBAR N/A
- IMCR 2021
- Fundamental
- Price
- BBAR $13.57
- IMCR $32.93
- Analyst Decision
- BBAR
- IMCR Buy
- Analyst Count
- BBAR 0
- IMCR 14
- Target Price
- BBAR N/A
- IMCR $74.75
- AVG Volume (30 Days)
- BBAR 597.6K
- IMCR 267.8K
- Earning Date
- BBAR 11-19-2024
- IMCR 11-05-2024
- Dividend Yield
- BBAR 12.13%
- IMCR N/A
- EPS Growth
- BBAR N/A
- IMCR N/A
- EPS
- BBAR 0.24
- IMCR N/A
- Revenue
- BBAR $2,631,545,762.00
- IMCR $280,914,000.00
- Revenue This Year
- BBAR N/A
- IMCR $25.60
- Revenue Next Year
- BBAR N/A
- IMCR $10.63
- P/E Ratio
- BBAR $22.13
- IMCR N/A
- Revenue Growth
- BBAR N/A
- IMCR 27.95
- 52 Week Low
- BBAR $3.86
- IMCR $29.72
- 52 Week High
- BBAR $14.45
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- BBAR 66.75
- IMCR 52.76
- Support Level
- BBAR $11.22
- IMCR $31.10
- Resistance Level
- BBAR $14.45
- IMCR $35.47
- Average True Range (ATR)
- BBAR 0.63
- IMCR 1.49
- MACD
- BBAR 0.21
- IMCR 0.17
- Stochastic Oscillator
- BBAR 70.11
- IMCR 51.98
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focused on foreign trade, agricultural business, and digital products.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.